5-FUMCL: A selective and low-hepatotoxicity NLRP3 inflammasome inhibitor for treating inflammatory diseases

Energy and Built Environment · Elsevier

Аннотация

Publication date: Available online 28 October 2026 Source: Journal of Pharmaceutical Analysis Author(s): Xuyun Liu, Ying Wen, Xinyu Liao, Shuang Wang, Yizhen Yan, Min Li, Sen Yu, Ziang Zhang, Jia Li, Jiankang Liu, Feng Gao, Xinghua Qin, Xiangyang Qin, Xing Zhang

Читать у издателя →

Похожие статьи